1. Home
  2. TNL vs RCUS Comparison

TNL vs RCUS Comparison

Compare TNL & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travel   Leisure Co.

TNL

Travel Leisure Co.

N/A

Current Price

$62.45

Market Cap

3.9B

ML Signal

N/A

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

N/A

Current Price

$25.25

Market Cap

3.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TNL
RCUS
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.2B
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
TNL
RCUS
Price
$62.45
$25.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
13
Target Price
★ $91.17
$39.91
AVG Volume (30 Days)
554.5K
★ 1.5M
Earning Date
10-27-2026
10-27-2026
Dividend Yield
★ 3.88%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.94
N/A
Revenue
★ $4,021,000,000.00
$247,000,000.00
Revenue This Year
$4.03
N/A
Revenue Next Year
$4.87
N/A
P/E Ratio
$21.70
★ N/A
Revenue Growth
★ 4.06
N/A
52 Week Low
$58.09
$13.21
52 Week High
$81.00
$31.74

Technical Indicators

Market Signals
Indicator
TNL
RCUS
Relative Strength Index (RSI) 27.83 45.70
Support Level N/A $25.94
Resistance Level $73.66 $26.43
Average True Range (ATR) 1.72 1.07
MACD 0.08 0.10
Stochastic Oscillator 0.00 58.61

Price Performance

Historical Comparison
TNL
RCUS

About TNL Travel Leisure Co.

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including two vacation exchange brands, Vacation Ownership and Travel and Membership The majority of the revenue is earned from the United States.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: